Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gynecomastia × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 4967 Carcinoma, Renal Cell 1559 Urinary Bladder Neoplasms 1273 Kidney Neoplasms 717 Breast Neoplasms 636 Neoplasms 623 Carcinoma, Transitional Cell 483 Neoplasm Metastasis 463 Carcinoma, Non-Small-Cell Lung 462 Melanoma 419 Ovarian Neoplasms 396 Colorectal Neoplasms 368 Lung Neoplasms 331 Pancreatic Neoplasms 260 Sarcoma 231 Stomach Neoplasms 226 Uterine Cervical Neoplasms 222 Testicular Neoplasms 213 Non-Muscle Invasive Bladder Neoplasms 213 Head and Neck Neoplasms 190 Squamous Cell Carcinoma of Head and Neck 185 Colonic Neoplasms 167 Esophageal Neoplasms 165 Carcinoma, Hepatocellular 165 Endometrial Neoplasms 164 Wilms Tumor 158 Recurrence 129 Triple Negative Breast Neoplasms 127 Neuroblastoma 126 Small Cell Lung Carcinoma 123

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡